(DPP-4) inhibitors Alogliptin,† Saxagliptin,† Sitagliptin, VildagliptinGlucagon-like peptide-1 analog ExenatideAmylin analog PramlintideInsulin analogs fast acting (Insulin glargine, Insulin detemir)Dual PPAR agonists Aleglitazar†, Muraglitazar§, Tesaglitazar§ GlimepirideFrom amaryl domain amarylcom the free encyclopedia(Redirected from.

searchThis article does not cite any references or sources. (November 2007)Please help improve this article by adding citations to reliable sources. Unverifiable material may be challenged and removed.GlimepirideSystematic (IUPAC) name3-ethyl-N,N-bis (3-ethyl-4-methyl-2-oxo-5H-pyrrol-2-yl)- 4-methyl-2-oxo-5H-pyrrole-1- carboxamideIdentifiersCAS number 93479-97-1ATC amaryl domain amarylcom A10BB12PubChem 3476DrugBank APRD00381Chemical dataFormula C24H34N4O5SMol. mass 490.617 amaryl domain amarylcom dataBioavailability amaryl domain amarylcom ?Protein binding >99.5%Metabolism ?Half life ?Excretion ?Therapeutic considerationsPregnancy cat. ?Legal statusRoutes ?Glimepiride is a medium-to-long acting sulfonylurea anti-diabetic drug. amaryl domain amarylcom is marketed as Amaryl by Sanofi-Aventis. Glimepiride is the first third-generation sulfonylurea, and is very potent.Contents [hide]1 Indications2 Adverse effects3 Contraindications4 Interactions5 amaryl domain amarylcom Mechanism of actionMain article: SulfonylureaGlimepiride distinctly amaryl domain amarylcom the blood.

Acarbose, Miglitol, VogliboseThiazolidinediones (TZD) Pioglitazone, Rivoglitazone†, Rosiglitazone.